USDM Life Sciences to Kick Off 2022 with an All-Star Event

SANTA BARBARA, Calif., Nov. 16, 2021 /PRNewswire-PRWeb/ — USDM Life Sciences, a premier consulting firm driving digital transformation and innovation in technology and compliance, announces its first tailor-made event, Forward-Thinking GxP Compliance and Process Optimization, happening on Thursday, January 27, 2022.

USDM, in partnership with Hanson Wade, is bringing together some of the most innovative thinkers at the intersection of compliance and technology, with companies like Accumulus, Google Cloud, Microsoft, Oracle, ServiceNow, and the FDA participating in thought-leading discussions.
These subject matter experts will share innovative ideas for regulated GxP workloads and discuss new case studies of life sciences companies advancing their cloud compliance maturity faster than ever.

This exclusive, virtual event will be available only to life sciences industry professionals looking to achieve continuous compliance and GxP process optimization. Attendees will gain forward-thinking perspectives on aligning their compliance and technology business objectives with a sustainable strategy for their regulated and non-regulated processes and data. It will provide the leverage to overcome cloud technology barriers and create a more data-powered business. IT and Quality professionals in biotech, medical devices, and pharma are invited to attend at no cost. Credentials will be required.

“The world is already digital, so moving to the cloud doesn’t mean you are innovating. Our mission is to disrupt conventional thinking with the brightest minds in the business and make transformative technology work for a human-centered purpose,” said Kevin Brown, CEO of USDM. “It’s the people that have the intellect and passion for driving game-changing results.”

To secure your front-row seat to these transformative discussions, register here.

About USDM Life Sciences

USDM Life Sciences provides strategy and compliant technology solutions to regulated life sciences companies and makes it easy to accelerate transformation and innovation. USDM Life Sciences focuses exclusively on the regulated biotechnology, pharmaceutical, and medical device industries and is a compliance partner with the world’s leading technology software developers. For more information, visit http://www.usdm.com.

Media Contact

Lisa Om, USDM Life Sciences, 1 8052961196, lom@usdm.com

Twitter

SOURCE USDM Life Sciences